Notice of Results
Summary by AI BETAClose X
Integrated Diagnostics Holdings Plc Notice of Results
04 September 2026
(London) Integrated Diagnostics Holdings ("IDH," "the Group," or "the Company"), a leading provider of diagnostic services with operations in Egypt, Jordan, Nigeria and Saudi Arabia will publish its unaudited financial results for the second quarter and first-half period ended 30 June 2026 on Friday, 11 September 2026 at 7am (UK).
An analyst and investor call will be hosted at 1pm (UK) | 3pm (Egypt) on Tuesday, 15 September 2026. You can learn more details and register for the call by clicking on this link.
https://irfiles.technologyverse.com/idh/IDH-H126-results-conference-call.pdf
For more information about the event, please contact: amoataz@EFG-HERMES.com
-Ends-
About Integrated Diagnostics Holdings (IDH)
IDH is a leading diagnostics services provider in the Middle East and Africa offering a broad range of clinical pathology and radiology tests to patients in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. The Group's core brands include Al Borg, Al Borg Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in Sudan), and Biolab KSA (Saudi Arabia). With over 40 years of experience, a long track record for quality and safety has earned the Company a trusted reputation, as well as internationally recognised accreditations for its portfolio of over 3,000 diagnostics tests. From its base of 767 branches as of 31 December 2025, IDH served over 9.4 million patients and performed more than 43.5 million tests in 2025. IDH will continue to add laboratories through a Hub, Spoke and Spike business model that provides a scalable platform for efficient expansion. Beyond organic growth, the Group targets expansion in appealing markets, including acquisitions in the Middle Eastern, African, and East Asian markets where its model is well-suited to capitalise on similar healthcare and consumer trends and capture a significant share of fragmented markets. IDH has been a Jersey-registered entity whose shares are admitted to the equity shares (transition) category (previously, the standard listing segment) of the Official List of the UK Financial Conduct Authority and admitted to trading on the main market for listed securities of the London Stock Exchange (ticker: IDHC) since May 2015.
The person responsible for arranging the release of this announcement is Mirette Ahmed, Investor Relations Officer at IDH.
Contact
Mirette Ahmed
Investor Relations Officer
T: +20 (0)2 3332 1126 | M: +20 1117847401 | Mirette.ahmed@idhcorp.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 9 hours ago Johnson Matthey
- 10 hours ago Galliford Try
- 10 hours ago Galliford Try
- 10 hours ago Centrica
- 11 hours ago Smith & Nephew